Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Cingulate (CINGW)

Cingulate Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CINGW
DateTimeSourceHeadlineSymbolCompany
14/06/202400:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
14/06/202400:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
14/06/202400:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
14/06/202400:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
14/06/202400:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
14/06/202400:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
14/06/202400:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
12/06/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
07/06/202423:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CINGWCingulate Inc
28/05/202422:54Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CINGWCingulate Inc
28/05/202414:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
24/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CINGWCingulate Inc
23/05/202422:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CINGWCingulate Inc
21/05/202414:00GlobeNewswire Inc.FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHDNASDAQ:CINGWCingulate Inc
17/05/202422:01Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CINGWCingulate Inc
13/05/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
08/05/202412:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CINGWCingulate Inc
08/05/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
08/05/202412:00GlobeNewswire Inc.Cingulate Reports First Quarter 2024 Financial ResultsĀ and Provides Clinical and Business UpdateNASDAQ:CINGWCingulate Inc
30/04/202410:45GlobeNewswire Inc.Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live AccessNASDAQ:CINGWCingulate Inc
16/04/202422:00GlobeNewswire Inc.Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024NASDAQ:CINGWCingulate Inc
01/04/202413:00GlobeNewswire Inc.Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsĀ and Provides Clinical and Business UpdateNASDAQ:CINGWCingulate Inc
19/03/202420:45GlobeNewswire Inc.Cingulate to Participate in Benzinga All Live Access EventNASDAQ:CINGWCingulate Inc
06/03/202411:45GlobeNewswire Inc.Cingulate to Attend DCAT Week 2024 in New York CityNASDAQ:CINGWCingulate Inc
13/02/202411:45GlobeNewswire Inc.Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of DirectorsNASDAQ:CINGWCingulate Inc
06/02/202421:15GlobeNewswire Inc.Cingulate Announces Closing of $7.5 Million Public OfferingNASDAQ:CINGWCingulate Inc
02/02/202414:15GlobeNewswire Inc.Cingulate Announces Pricing of $7.5 Million Public OfferingNASDAQ:CINGWCingulate Inc
29/01/202413:00GlobeNewswire Inc.Longtime Cingulate Controller Jennifer Callahan Promoted to CFONASDAQ:CINGWCingulate Inc
29/01/202411:45GlobeNewswire Inc.Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to MarketNASDAQ:CINGWCingulate Inc
01/12/202314:00GlobeNewswire Inc.Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)NASDAQ:CINGWCingulate Inc
 Showing the most relevant articles for your search:NASDAQ:CINGW

Your Recent History